Ace Blend Secures $9.9 Mn to Expand Nutrition Products and Clinical Research

Founded in 2018, Ace Blend is an Indian direct-to-consumer (D2C) nutrition and dietary supplements brand. The company focuses on products designed to support different health needs, including gut health, immunity, sleep, recovery and heart health.

Funding Details

Ace Blend Secures $9.9 million (approximately ₹95 crore) in its latest Series A2 round. The investment was led by 3one4 Capital, while Fireside Ventures also participated.

The company plans to invest in scientific research, product testing and manufacturing operations. The funding will also support the development of new nutrition formats and improvements to its supply chain.

How Will Ace Blend Use the Funding?

The company plans to conduct clinical trials through contract research organisations (CROs), with the aim of publishing the findings in peer-reviewed international journals. These studies are expected to help build scientific evidence for its products.

Ace Blend will also invest in shelf-stability studies to assess product quality over time. In addition, it is working towards automated testing of every product batch to check nutritional accuracy and screen for pesticide residues and heavy metals.

Products and Business Model

Ace Blend offers around 14 stock-keeping units (SKUs), including plant-based protein powders, superfood mixes and functional health supplements. Its product range covers areas such as brain health, gut health, strength, immunity, sleep and recovery.

The company sells its products through its official website and online platforms, including Amazon, Flipkart, Zepto and Blinkit.

Ace Blend follows a vertically integrated model that covers ingredient sourcing, product formulation and manufacturing. According to the company, its website contributes around 50% of its revenue, while the rest comes from marketplaces and other online sales channels.

Growth and Future Plans

According to founder and CEO Shivam Hingorani, Ace Blend recorded 300% growth in FY26 and a repeat purchase rate of nearly 48%.

The company is targeting annual recurring revenue (ARR) of ₹250 crore to ₹300 crore over the next 12–18 months. It is also aiming to achieve profitability as it expands its product portfolio and strengthens its operations.

Ace Blend is developing several new products, including a gut-health formulation designed with a specialist, an anti-inflammatory nutrient blend, an eye-health supplement and a fibre-based product for gut health.

About Ace Blend

Ace Blend is a nutrition and dietary supplements company founded in 2018 by Shivam Hingorani. Saif Mehkri joined the company as a co-founder in 2022. The company develops and sells functional nutrition products through its direct-to-consumer website and online marketplaces.

With its latest funding, Ace Blend plans to strengthen scientific validation, improve product quality testing and expand its range of nutrition products.

Read Also - Geleximco and Chery Partner to Explore Chips, Robotics and Green Energy